Felippe Borlot, MD, MSc

Research Interests

  • Epilepsy Genetics
  • Epilepsy, Transition from Childhood to Adulthood

Languages

  • English
  • Portuguese

Academic Information

  • Departments: Neurology - Assistant Professor (Clinical)
  • Divisions: Epilepsy

Academic Office Information

  • 801-585-7575
  • Clinical Neurosciences Center
    175 North Medical Drive East
    Salt Lake City, UT 84132

Academic Bio

Dr. Borlot is an Assistant Professor at the University of Utah School of Medicine. He is both clinical and research faculty in the Division of Epilepsy within the Department of Neurology. He was born in Brazil, where he attended medical school and completed residency. Dr. Borlot was also a chief resident and pursued an additional year as residents' preceptor at Universidade de Sao Paulo. Prior to joining the University of Utah, Dr. Borlot furthered his training with a clinical and research fellowship in adult epilepsy at the University of Toronto, Canada. His training and experience focus on the evaluation and management of patients with longstanding history of seizures in transition from childhood to adulthood, as well as the underlying genetic causes of certain forms of epilepsy.

Specialties: epilepsy, EEG, transistion of care from childhood to adulthood, epilepsy genetics

Education History

Type School Degree
Fellowship University of Toronto
Epilepsy & EEG Programs
Clinical Research Fellow
Fellowship Hospital for Sick Children
Neurometabolics
Clinical Fellow
Graduate Training Universidade de São Paulo
M.Sc.
Preceptorship Universidade de São Paulo
Pediatric Neurology
Preceptorship
Chief Resident Universidade de São Paulo
Child Neurology
Chief Resident
Residency Universidade de São Paulo
Pediatric Neurology
Resident
Residency Universidade de São Paulo
Pediatrics
Resident
Professional Medical Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória
Medicine
M.D.

Global Impact

Education History

Type School Degree Country
Fellowship University of Toronto
Epilepsy & EEG Programs
Clinical Research Fellow Canada
Fellowship Hospital for Sick Children
Neurometabolics
Clinical Fellow Canada
Graduate Training Universidade de São Paulo
M.Sc. Brazil
Preceptorship Universidade de São Paulo
Pediatric Neurology
Preceptorship Brazil
Chief Resident Universidade de São Paulo
Child Neurology
Chief Resident Brazil
Residency Universidade de São Paulo
Pediatric Neurology
Resident Brazil
Residency Universidade de São Paulo
Pediatrics
Resident Brazil
Professional Medical Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória
Medicine
M.D. Brazil

Grand Rounds

Description Country
Felippe Borlot, MD, MSc. Neurological Approach do Mucopolysaccharidosis. Pediatric Grand Rounds. University of Manitoba, Winnipeg, MB, Canada. Canada

Career

Institution Description Country
Private Practice Neurologist Brazil
Hospital Santa Marcelina Pediatric Neurologist Attending Physician Brazil

Selected Publications

Journal Article

  1. Rezazadeh A, Borlot F, Faghfoury H, Andrade DM (2017). Genetic generalized epilepsy in three siblings with 8q21.13-q22.2 duplication. Seizure, 48, 57-61.
  2. Wither RG, Borlot F, MacDonald A, Butcher NJ, Chow EWC, Bassett AS, Andrade DM (2017). 22q11.2 deletion syndrome lowers seizure threshold in adult patients without epilepsy. Epilepsia, 58(6), 1095-1101.
  3. Andrade DM, Bassett AS, Bercovici E, Borlot F, Bui E, Camfield P, Clozza GQ, Cohen E, Gofine T, Graves L, Greenaway J, Guttman B, Guttman-Slater M, Hassan A, Henze M, Kaufman M, Lawless B, Lee H, Lindzon L, Lomax LB, McAndrews MP, Menna-Dack D, Minassian BA, Mulligan J, Nabbout R, Nejm T, Secco M, Sellers L, Shapiro M, Slegr M, Smith R, Szatmari P, Tao L, Vogt A, Whiting S, Carter Snead O 3rd (2017). Epilepsy: Transition from pediatric to adult care. Recommendations of the Ontario epilepsy implementation task force. Epilepsia, 58(9), 1502-1517.
  4. Borlot F, Regan BM, Bassett AS, Stavropoulos DJ, Andrade DM (2017). Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability. JAMA Neurol, 74(11), 1301-1311.
  5. Wissel BD, Dwivedi AK, Gaston TE, Rodriguez-Porcel FJ, Aljaafari D, Hopp JL, Krumholz A, van der Salm SM, Andrade DM, BORLOT F, Moseley BD, Cavitt JL, Williams S, Stone J, LaFrance WC Jr, Szaflarski JP, Espay AJ (2016). Which patients with epilepsy are at risk for psychogenic nonepileptic seizures (PNES)? A multicenter case-control study. Epilepsy Behav, 61, 180-184.
  6. Nascimento FA, BORLOT F, Aljaafari D, Del Campo M (2016). Active Search for Epileptiform Electroencephalogram Activity by External Stimulation in Critically Ill Patients. Can J Neurol Sci, 18, 1-3.
  7. Nascimento FA, BORLOT F, Cossette P, Minassian BA, Andrade DM (2015). Two definite cases of sudden unexpected death in epilepsy in a family with a DEPDC5 mutation. Neurol Genet, 1(4), e28.
  8. BORLOT F, Arantes PR, Capel-Cardoso AC, Kim CA (2014). Remote Spinal Cord Injury in Mucopolysaccharidosis type IVA after Cervical Decompression. Neurology, 82, 1382-1383.
  9. Borlot F, Arantes PR, Quaio CR, Franco JF, Lourenco CM, Bertola DR, Kim CA (2014). New insights in mucopolysaccharidosis type VI: neurological perspective. Brain Dev, 36(7), 585-92.
  10. Borlot F, Arantes PR, Quaio CR, Franco JF, Lourenco CM, Gomy I, Bertola DR, Kim CA (2014). Mucopolysaccharidosis type IVA: evidence of primary and secondary central nervous system involvement. Am J Med Genet A, 164A(5), 1162-9.
  11. Wu N, Borlot F, Ali A, Krings T, Andrade DM (2014). Hemimegalencephaly: what happens when children get older? Dev Med Child Neurol, 56(9), 905-9.
  12. Fasano A, Borlot F, Lang AE, Andrade DM (2014). Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome. Neurology, 82(24), 2250-1.
  13. Borlot F, Tellez-Zenteno JF, Allen A, Ali A, Snead OC 3rd, Andrade DM (2014). Epilepsy transition: challenges of caring for adults with childhood-onset seizures. Epilepsia, 55(10), 1659-66.
  14. Borlot F, Wither RG, Ali A, Wu N, Verocai F, Andrade DM (2014). A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures. Epilepsy Res, 108(9), 1642-51.